Arthramid Vet is used to treat non-infectious causes of joint lameness in animals, including the early and late stages of osteoarthritis (OA).
Arthramid Vet is an injectable, biocompatible, non-absorbable, non-pyrogenic, neuroinogenic joint injection in The gel is progressively integrated into the synovial mucosa and the immediately surrounding tissue of the inner joint capsule through a combination of cell migration and vascular growth with the formation of a thick pillow-shaped membrane over 14 to 28 Days consisting of clinical studies show that tissue integration and subsequent enlargement of the joint capsule takes 2 to 4 weeks to appear, although in some cases an earlier response to treatment is seen.
2.5% polyacrylamide hydrogel was developed as a long-acting intra-articular injection for the treatment of osteoarthritis in humans. Started after generating impressive clinical data with Arthramid Vet in the treatment of lameness in horses Hydrogel for intra-articular injection in animals The gel is gradually integrated into the synovial mucosa and the immediately surrounding tissue of the inner joint capsule through a combination of migration to form cell and vascular growth 14 up to 28 days, a thick pillow-shaped membrane consisting of a gel that is integrated into the vessels, which are covered by a new and hypercellular membrane.
Clinical studies show that tissue integration and the subsequent enlargement of the joint capsule take 2 to 4 days. Weeks, although response to treatment can be seen earlier in some cases